For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Dietary Supplementation of Glycocalyx Precursors (DSGP) | Participants will daily ingest 3,712mg (i.e., six capsules) of DSGP for eight weeks. DSGP, commercially available as Endocalyx (Microvascular Health Solutions LLC, Alpine, UT), include glucosamine sulfate, fucoidan, superoxide dismutase, and high molecular weight hyaluronan. Endocalyx: 3,712mg (six capsules) of DSGP for eight weeks. | 0 | None | 0 | 12 | 4 | 12 | View |
| Placebo | Participants will daily ingest 6 capsules daily of placebo for eight weeks. Placebo: Ingredients per capsule (6 capsules per day) Nu-Mag Nat 10.00mg Rice Flour White 830 mg Magnesium Stearate 10.00mg | 0 | None | 0 | 12 | 3 | 12 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Tendon injury | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Loose stools | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Stomach Ache | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| PT/PTT lab elevation | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Itchiness | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Hemorrhoids | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |